Banggulan, Fritchel A.

HRN: 20-43-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2022
CEFUROXIME 500MG (TAB)
07/02/2022
07/08/2022
IVT
60mg
Q12 For 7 Days
Uti
07/04/2022
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
07/04/2022
07/10/2022
PO
2ml
Bid
Uti
Waiting Final Action 
07/04/2022
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
07/04/2022
07/11/2022
IV
0.6ml
Q12
UTI

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: